SCHEDULE 13G/A: AWM Investment Company Discloses 10.3% Stake in MDxHealth SA

AWM Investment Company, Inc. has filed an amended Schedule 13G, revealing a 10.3% beneficial ownership stake in MDxHealth SA as of January 31, 2025.

Summary

• AWM Investment Company, Inc. (AWM), a Delaware corporation, has reported beneficial ownership of 4,875,782 shares of Common Stock in MDxHealth SA.
• This ownership represents 10.3% of the class of securities.
• AWM acts as the investment adviser to four funds: Special Situations Cayman Fund, L.P. (782,620 shares), Special Situations Fund III QP, L.P. (2,808,109 shares), Special Situations Private Equity Fund, L.P. (694,444 shares), and Special Situations Life Sciences Fund, L.P. (590,609 shares).
• AWM holds sole voting and investment power over all these shares.
• The filing is an Amendment No. 1 to a Schedule 13G, indicating a change from a previous filing.
• The shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing the control of MDxHealth SA.

Sentiment

Score: 5

Explanation: The document is a factual beneficial ownership report and does not contain information that would typically lead to a positive or negative sentiment regarding the company's operational or financial performance. It is neutral in tone and content, simply disclosing an ownership stake.

Positives

• The disclosure of a significant 10.3% stake by AWM Investment Company, a professional investment adviser, may be viewed as a vote of confidence in MDxHealth SA's long-term prospects by a sophisticated institutional investor.

Risks

• The document does not explicitly state risks related to the issuer's operations or financial health, as it is a beneficial ownership report. However, any significant institutional ownership could, in general, lead to increased scrutiny or potential for activist involvement, though AWM has certified its passive intent.

Future Outlook

This document, a Schedule 13G, is a beneficial ownership report and does not contain forward-looking statements or guidance regarding MDxHealth SA's future performance or strategic outlook.

Management Comments

• AWM Investment Company, Inc. certified that the securities were acquired and are held in the ordinary course of business and not for the purpose of or with the effect of changing or influencing the control of MDxHealth SA, nor in connection with any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 240.14a-11.

Industry Context

This filing is a disclosure of beneficial ownership by an investment adviser and does not provide specific insights into broader industry trends or competitive landscape for MDxHealth SA. It primarily reflects an investment decision by AWM Investment Company, Inc. within the healthcare or diagnostics sector.

Stakeholder Impact

• Shareholders of MDxHealth SA are informed of a significant institutional investor, AWM Investment Company, Inc., holding a 10.3% stake, which could influence market perception and trading activity.

Key Dates

Keywords

MDxHealth SA, AWM Investment Company, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, SEC Filing, Investment Adviser, Equity Stake